Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
Aids Research And Therapy
Silver, Nicholas N; Paynter, Mary M; McAllister, Georgina G; Atchley, Maureen M; Sayir, Christine C; Short, John J; Winner, Dane D; Alouani, David J DJ; Sharkey, Freddie H FH; Bergefall, Kicki K; Templeton, Kate K; Carrington, David D; Quiñones-Mateu, Miguel E ME
Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Scientific Reports
Teto, Georges G; Tagny, Claude T CT; Mbanya, Dora D; Fonsah, Julius Y JY; Fokam, Joseph J; Nchindap, Emilienne E; Kenmogne, Léopoldine L; Njamnshi, Alfred K AK; Kanmogne, Georgette D GD
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
The Journal Of Infectious Diseases
Mollan, Katie K; Daar, Eric S ES; Sax, Paul E PE; Balamane, Maya M; Collier, Ann C AC; Fischl, Margaret A MA; Lalama, Christina M CM; Bosch, Ronald J RJ; Tierney, Camlin C; Katzenstein, David D; ,
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.
Journal Of Clinical Microbiology
Ndembi, Nicaise N; Abraha, Awet A; Pilch, Heather H; Ichimura, Hiroshi H; Mbanya, Dora D; Kaptue, Lazare L; Salata, Robert R; Arts, Eric J EJ